Amylyx

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?
BioSpace
Wed, 04/17/24 - 11:22 am
Amylyx
Relyvrio
ALS
European study finds popular ALS drug ineffective
BioPharma Dive
Wed, 03/27/24 - 10:31 pm
Amylyx
TUDCA
ALS
clinical trials
Europe
Setbacks reset views on highly touted Alzheimer's and ALS drugs
Axios
Mon, 03/11/24 - 05:06 pm
Alzheimer's disease
ALS
Amylyx
Relyvrio
Eli Lilly
donanemab
After trial failure, will Amylyx pull ALS drug Relyvrio off the market?
Fierce Pharma
Fri, 03/8/24 - 11:33 am
Amylyx
ALS
Relyvrio
Amylyx’s ALS drug could face rejection in Europe
BioPharma Dive
Wed, 05/31/23 - 10:45 am
Amylyx
ALS
EMA
Europe
Relyvrio
3 Biotechs That Might Get Bought Out in 2023
Motley Fool
Wed, 04/26/23 - 05:41 pm
M&A
Madrigal Pharmaceuticals
Amylyx
Aurinia Pharmaceuticals
Amylyx’s ALS drug sales impress Wall Street
BioPharma Dive
Tue, 03/14/23 - 11:28 am
Amylyx
ALS
Relyvrio
Amylyx completes subject enrollment in ALS therapy trial
Clinical Trials Arena
Fri, 02/3/23 - 10:33 am
Amylyx
clinical trials
AMX0035
ALS
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
BioPharma Dive
Thu, 12/15/22 - 10:58 am
Amylyx
Relyvrio
ALS
patients
physicians
FDA seems poised to approve a new drug for ALS, but does it work?
NPR
Wed, 09/21/22 - 10:12 am
Amylyx
AX0035
FDA
ALS
Highlighted by Amylyx, the ALS Space is Gaining Momentum
BioSpace
Fri, 09/9/22 - 11:11 am
ALS
AMX0035
Amylyx
GeNeuro
NeuroSense Therapeutics
BrainStorm Cell Therapeutics
FDA advisers back Amylyx ALS drug, reversing earlier position
BioPharma Dive
Thu, 09/8/22 - 12:00 am
Amylyx
FDA
ALS
AMX0035
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
FDA to reconvene experts' meeting for Amylyx ALS drug
Yahoo/Reuters
Tue, 07/5/22 - 10:48 am
Amylyx
ALS
FDA
AMX0035
Go or no go? The FDA’s Amylyx dilemma
EP Vantage
Tue, 05/31/22 - 10:29 am
FDA
Amylyx
AMX0035
ALS
COVID-19
vaccines
Novavax
Moderna Therapeutics
Pfizer
Acadia Pharma
Bluebird Bio
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway
Fierce Biotech
Thu, 03/31/22 - 10:48 am
Amylyx
ALS
FDA
patients
AMX0035
Amylyx faces an uphill battle
EP Vantage
Wed, 03/30/22 - 10:42 am
Amylyx
FDA
AMX0035
Amylyx to answer for single-study ALS application at FDA advisory panel
Fierce Biotech
Mon, 03/28/22 - 07:46 pm
Amylyx
ALS
clinical trials
FDA
As three biotechs head to Wall Street, a battered sector braces for a pullback
BioPharma Dive
Fri, 01/7/22 - 10:34 am
Amylyx
CinCor
Vigil Neuroscience
IPOs
biotech
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Endpoints
Fri, 12/17/21 - 11:01 am
Amylyx
ALS
funding
NASDAQ

Pages